GlaxoSmithKline Notes Positive Tango And Gemini HIV Study Results
(Alliance News) - GlaxoSmithKline PLC on Wednesday noted positive results from the Gemini and Tango phase three studies of a dolutegravir plus lamivudine in HIV patients.The results were by Read More